Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

ALT – Altimmune Inc

[iframe https://s.tradingview.com/embed-widget/symbol-info/?locale=in&symbol=ALT #%7B%22symbol%22%3A%22A%22%2C%22width%22%3A%22100%25%22%2C%22colorTheme%22%3A%22light%22%2C%22isTransparent%22%3Atrue%2C%22height%22%3A203%2C%22utm_source%22%3A%22themarketstracker.com%22%2C%22utm_medium%22%3A%22widget_new%22%2C%22utm_campaign%22%3A%22symbol-info%22%7D 900 250 ]
[iframe https://api.stockdio.com/visualization/financial/charts/v1/PricesChange?app-key=F086EEE750E14D8D8A456DB88B2D6D8C&symbol=ALT &conditionalVolume=false&allowPeriodChange=false&tooltipsStyle=None&palette=Financial-Light&showBorderAndTitle=false 300 200 ]

Float Short %

29.5

Margin Of Safety %

Put/Call OI Ratio

0.25

EPS Next Q Diff

-0.05

EPS Last/This Y

0.22

EPS This/Next Y

-0.22

Price

3.53

Target Price

18.44

Analyst Recom

1.6

Performance Q

-38.65

Relative Volume

0.49

Beta

0.18

Ticker: ALT




21 items of 1

DateSymbolLastP/C OIP/C VolTotal OI
2025-07-25ALT4.070.230.17176080
2025-07-28ALT4.030.230.59169944
2025-07-29ALT3.830.240.28174502
2025-07-30ALT3.650.242.13176286
2025-07-31ALT3.690.280.20182597
2025-08-01ALT3.610.280.27182624
2025-08-04ALT3.580.280.32177081
2025-08-05ALT3.660.270.23179191
2025-08-06ALT3.610.270.40179943
2025-08-07ALT3.520.270.35180409
2025-08-08ALT3.440.270.12180923
2025-08-11ALT3.380.260.46179244
2025-08-12ALT3.610.260.28183304
2025-08-13ALT3.740.260.24189027
2025-08-14ALT3.670.260.10190997
2025-08-15ALT3.620.260.20191991
2025-08-18ALT3.550.260.16180668
2025-08-19ALT3.60.250.21184384
2025-08-20ALT3.620.250.39187920
2025-08-21ALT3.530.250.21190162
2025-08-22ALT3.540.250.17190912
DateSymbolLastP/C OIP/C VolTotal OI
21 items Current Page1 of 1




21 items of 1

DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
2025-07-25ALT4.0814.1-20.5-1.27
2025-07-28ALT4.0314.1-19.4-1.27
2025-07-29ALT3.8314.1-11.4-1.27
2025-07-30ALT3.6514.1-11.6-1.27
2025-07-31ALT3.6914.1-24.7-1.27
2025-08-01ALT3.618.4-17.1-1.23
2025-08-04ALT3.588.4-19.7-1.23
2025-08-05ALT3.678.4-27.3-1.23
2025-08-06ALT3.618.4-17.7-1.23
2025-08-07ALT3.528.4-16.4-1.23
2025-08-08ALT3.458.4-17.8-1.23
2025-08-11ALT3.378.4-16.0-1.23
2025-08-12ALT3.608.4-38.0-1.23
2025-08-13ALT3.748.4-29.3-1.23
2025-08-14ALT3.678.4-20.0-1.23
2025-08-15ALT3.628.4-8.5-1.12
2025-08-18ALT3.5616.29.0-1.12
2025-08-19ALT3.628.4-15.7-1.12
2025-08-20ALT3.628.4-12.2-1.12
2025-08-21ALT3.538.4-5.9-1.12
2025-08-22ALT3.5316.2-12.2-1.12
DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
21 items Current Page1 of 1




21 items of 1

DateTickerInsider TransactionsInstitutional TransactionsFloat Short
2025-07-25ALT1.32-5.3935.01
2025-07-28ALT1.32-5.2835.01
2025-07-29ALT1.32-5.2835.01
2025-07-30ALT1.32-5.2835.01
2025-07-31ALT1.32-5.2835.01
2025-08-01ALT1.32-5.2835.01
2025-08-04ALT1.32-5.8935.01
2025-08-05ALT1.32-5.8935.01
2025-08-06ALT1.32-5.8935.01
2025-08-07ALT1.32-5.8935.01
2025-08-08ALT1.32-5.8935.01
2025-08-11ALT1.32-5.3235.01
2025-08-12ALT1.31-5.3232.10
2025-08-13ALT1.31-5.3232.10
2025-08-14ALT1.31-5.3232.10
2025-08-15ALT1.20-5.3229.50
2025-08-18ALT1.20-1.1429.50
2025-08-19ALT1.20-1.1429.50
2025-08-20ALT1.20-1.1429.50
2025-08-21ALT1.20-1.1429.50
2025-08-22ALT1.20-1.1429.50
DateTickerInsider TransactionsInstitutional TransactionsFloat Short
21 items Current Page1 of 1

[iframe https://widget.finnhub.io/widgets/historical-eps?symbol=ALT 589 360 ]

Last Quarter Act. EPS

-0.27

Avg. EPS Est. Current Quarter

-0.27

Avg. EPS Est. Next Quarter

-0.32

Insider Transactions

1.2

Institutional Transactions

-1.14

Beta

0.18

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

23

Growth Score

22

Sentiment Score

14

Actual DrawDown %

85.7

Max Drawdown 5-Year %

-91.2

Target Price

18.44

P/E

Forward P/E

PEG

P/S

15621.63

P/B

1.87

P/Free Cash Flow

EPS

-1.18

Average EPS Est. Cur. Y​

-1.12

EPS Next Y. (Est.)

-1.33

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

-438730

Relative Volume

0.49

Return on Equity vs Sector %

-79.1

Return on Equity vs Industry %

-66.2

EPS 1 7Days Diff

0.1

EPS 1 30Days Diff

0.12

EBIT Estimation

-12.2
[iframe https://widget.finnhub.io/widgets/recommendation?symbol=ALT 589 450 ]
[iframe https://widget.finnhub.io/widgets/eps-estimate?symbol=ALT 589 450 ]
Altimmune, Inc.
Sector: Healthcare
Industry: Biotechnology
Employees: 59
Altimmune, Inc., a clinical stage biopharmaceutical company, focuses on developing treatments for obesity, metabolic, and liver diseases. Its lead product candidate is pemvidutide, a GLP-1/glucagon dual receptor agonist, which is in Phase 3 trial for the treatment of obesity and metabolic associated steatohepatitis. The company was founded in 1997 and is headquartered in Gaithersburg, Maryland.
stock quote shares ALT – Altimmune Inc Stock Price stock today
news today ALT – Altimmune Inc stock forecast ,stock prediction 2023 2024 2025
marketwatch ALT – Altimmune Inc yahoo finance google finance
stock history ALT – Altimmune Inc invest stock market
stock prices ALT premarket after hours
ticker ALT fair value insiders trading

ALT – Altimmune, Inc.

Float Short %

29.5

Margin Of Safety %

Put/Call OI Ratio

0.25

EPS Next Q Diff

-0.05

EPS Last/This Y

0.22

EPS This/Next Y

-0.22

Price

3.53

Target Price

18.44

Analyst Recom

1.6

Performance Q

-38.65

Relative Volume

0.49

Beta

0.18

Ticker: ALT




21 items of 1

DateSymbolLastP/C OIP/C VolTotal OI
2025-07-25ALT4.070.230.17176080
2025-07-28ALT4.030.230.59169944
2025-07-29ALT3.830.240.28174502
2025-07-30ALT3.650.242.13176286
2025-07-31ALT3.690.280.20182597
2025-08-01ALT3.610.280.27182624
2025-08-04ALT3.580.280.32177081
2025-08-05ALT3.660.270.23179191
2025-08-06ALT3.610.270.40179943
2025-08-07ALT3.520.270.35180409
2025-08-08ALT3.440.270.12180923
2025-08-11ALT3.380.260.46179244
2025-08-12ALT3.610.260.28183304
2025-08-13ALT3.740.260.24189027
2025-08-14ALT3.670.260.10190997
2025-08-15ALT3.620.260.20191991
2025-08-18ALT3.550.260.16180668
2025-08-19ALT3.60.250.21184384
2025-08-20ALT3.620.250.39187920
2025-08-21ALT3.530.250.21190162
2025-08-22ALT3.540.250.17190912
DateSymbolLastP/C OIP/C VolTotal OI
21 items Current Page1 of 1




21 items of 1

DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
2025-07-25ALT4.0814.1-20.5-1.27
2025-07-28ALT4.0314.1-19.4-1.27
2025-07-29ALT3.8314.1-11.4-1.27
2025-07-30ALT3.6514.1-11.6-1.27
2025-07-31ALT3.6914.1-24.7-1.27
2025-08-01ALT3.618.4-17.1-1.23
2025-08-04ALT3.588.4-19.7-1.23
2025-08-05ALT3.678.4-27.3-1.23
2025-08-06ALT3.618.4-17.7-1.23
2025-08-07ALT3.528.4-16.4-1.23
2025-08-08ALT3.458.4-17.8-1.23
2025-08-11ALT3.378.4-16.0-1.23
2025-08-12ALT3.608.4-38.0-1.23
2025-08-13ALT3.748.4-29.3-1.23
2025-08-14ALT3.678.4-20.0-1.23
2025-08-15ALT3.628.4-8.5-1.12
2025-08-18ALT3.5616.29.0-1.12
2025-08-19ALT3.628.4-15.7-1.12
2025-08-20ALT3.628.4-12.2-1.12
2025-08-21ALT3.538.4-5.9-1.12
2025-08-22ALT3.5316.2-12.2-1.12
DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
21 items Current Page1 of 1




21 items of 1

DateTickerInsider TransactionsInstitutional TransactionsFloat Short
2025-07-25ALT1.32-5.3935.01
2025-07-28ALT1.32-5.2835.01
2025-07-29ALT1.32-5.2835.01
2025-07-30ALT1.32-5.2835.01
2025-07-31ALT1.32-5.2835.01
2025-08-01ALT1.32-5.2835.01
2025-08-04ALT1.32-5.8935.01
2025-08-05ALT1.32-5.8935.01
2025-08-06ALT1.32-5.8935.01
2025-08-07ALT1.32-5.8935.01
2025-08-08ALT1.32-5.8935.01
2025-08-11ALT1.32-5.3235.01
2025-08-12ALT1.31-5.3232.10
2025-08-13ALT1.31-5.3232.10
2025-08-14ALT1.31-5.3232.10
2025-08-15ALT1.20-5.3229.50
2025-08-18ALT1.20-1.1429.50
2025-08-19ALT1.20-1.1429.50
2025-08-20ALT1.20-1.1429.50
2025-08-21ALT1.20-1.1429.50
2025-08-22ALT1.20-1.1429.50
DateTickerInsider TransactionsInstitutional TransactionsFloat Short
21 items Current Page1 of 1

Last Quarter Act. EPS

-0.27

Avg. EPS Est. Current Quarter

-0.27

Avg. EPS Est. Next Quarter

-0.32

Insider Transactions

1.2

Institutional Transactions

-1.14

Beta

0.18

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

23

Growth Score

22

Sentiment Score

14

Actual DrawDown %

85.7

Max Drawdown 5-Year %

-91.2

Target Price

18.44

P/E

Forward P/E

PEG

P/S

15621.63

P/B

1.87

P/Free Cash Flow

EPS

-1.18

Average EPS Est. Cur. Y​

-1.12

EPS Next Y. (Est.)

-1.33

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

-438730

Relative Volume

0.49

Return on Equity vs Sector %

-79.1

Return on Equity vs Industry %

-66.2

EPS 1 7Days Diff

0.1

EPS 1 30Days Diff

0.12

EBIT Estimation

-12.2
Altimmune, Inc.
Sector: Healthcare
Industry: Biotechnology
Employees: 59
Altimmune, Inc., a clinical stage biopharmaceutical company, focuses on developing treatments for obesity, metabolic, and liver diseases. Its lead product candidate is pemvidutide, a GLP-1/glucagon dual receptor agonist, which is in Phase 3 trial for the treatment of obesity and metabolic associated steatohepatitis. The company was founded in 1997 and is headquartered in Gaithersburg, Maryland.
stock quote shares ALT – Altimmune, Inc. Stock Price stock today
news today ALT – Altimmune, Inc. stock forecast ,stock prediction 2023 2024 2025
marketwatch ALT – Altimmune, Inc. yahoo finance google finance
stock history ALT – Altimmune, Inc. invest stock market
stock prices ALT premarket after hours
ticker ALT fair value insiders trading